Skip to content
Nonprofiteer
← All organizations

CUREBOUND INC

EIN 46-0552414 SAN DIEGO, CA

Revenue 2025
$10,968,237
Expenses 2025
$14,851,654

Program services were 78.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
03
NTEE code
G123
Classification
1000
Street
9605 SCRANTON RD STE 120

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • DONALD B KEARNS MD MMM

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JOHN HOOD PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • ROB SINGH

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • HAEYOUNG TANG PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • FE WHITWORTH

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • DAN RYAN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • COURT TURNER JD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • MARK CAFFERTY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • CATRIONA JAMIESON MD PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • RICH HEYMAN PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • MAGDA MARQUET PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JULIE TAFEL KLAUS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • CHERYL AM ANDERSON PHD MPH MS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • CHRIS TRESSE

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • LARRY BLOCH

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • AARON DAVIS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • BILL KOMAN

    CHAIRPERSON

    Total calculated
    $0
    Hours/week
    1
  • KAREN HOOPER

    CHIEF OPERATING OFFICER

    Total calculated
    $325,985
    From this org
    $306,167
    From related orgs
    $0
    Other
    $19,818
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $220,500
    Bonus
    $85,667
    Other
    $0
    Deferred
    $11,043
    Nontaxable benefits
    $8,775
    Filer's total
    $325,985
  • ROBIN TOFT

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • DON ANKENY

    TREASURER

    Total calculated
    $0
    Hours/week
    1
  • RICK VALENCIA

    VICE-CHAIR

    Total calculated
    $0
    Hours/week
    1
  • ANNE MARBARGER

    CHIEF EXECUTIVE OFFICER

    Total calculated
    $497,091
    From this org
    $476,750
    From related orgs
    $0
    Other
    $20,341
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $323,750
    Bonus
    $153,000
    Other
    $0
    Deferred
    $13,470
    Nontaxable benefits
    $6,871
    Filer's total
    $497,091
  • MEGAN AMBROSE

    CHIEF OF STAFF

    Total calculated
    $149,791
    From this org
    $142,448
    From related orgs
    $0
    Other
    $7,343
    Hours/week
    40
  • HEATHER DEAN-PRESNALL

    SR. DIRECTOR, STEWARDSHIP

    Total calculated
    $163,962
    From this org
    $149,198
    From related orgs
    $0
    Other
    $14,764
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $130,729
    Bonus
    $18,469
    Other
    $0
    Deferred
    $5,989
    Nontaxable benefits
    $8,775
    Filer's total
    $163,962
  • JUDITH POLHA

    DIRECTOR, RESEARCH & IMPACT

    Total calculated
    $142,639
    From this org
    $137,153
    From related orgs
    $0
    Other
    $5,486
    Hours/week
    40

The first 25 listed. Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

  • 2025
    Revenue
    $10,968,237
    Expenses
    $14,851,654
    Contributions
    $7,968,991
    Grants paid
    $10,238,599
  • 2023
    Revenue
    $10,395,528
    Expenses
    $12,500,342
    Contributions
    $7,931,168
    Grants paid
    $8,400,965
  • 2022
    Revenue
    $19,804,413
    Expenses
    $6,229,069
    Contributions
    $18,221,209
    Grants paid
    $2,998,145

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Grants made

  • 2025 SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

  • 2023 Support Cancer Research

  • 2025 SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

  • 2022 Support Cancer Research

  • 2025 SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

  • 2023 Support Cancer Research

  • 2025 SEE DETAIL IN PART IVCUREBOUND AWARDS GRANT FUNDING IN EARLY-DISCOVERY CANCER RESEARCH AND APPLIES SCIENTIFIC AND ENTREPRENEURIAL EXPERTISE TO HELP PROMISING RESEARCH TRANSLATE INTO MEANINGFUL NEAR-TERM CLINICAL IMPACT. FUNDING IS DIRECTED TOWARD FIVE TRADITIONALLY UNDER-RESOURCED RESEARCH PILLARS: CANCER DETECTION, NOVEL APPROACHES, TARGETS, AND THERAPEUTICS. PERSONALIZED IMMUNOTHERAPY, CANCER EQUITY, CHILDHOOD CANCERS.

  • 2022 Support Cancer Research

  • 2022 Support Cancer Research

  • 2022 Support Cancer Research

The 10 largest by cash amount. The API serves every itemized grant.

Where these grants went next →

Grants received

The 10 largest by cash amount. The API serves every itemized grant.

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Listed as of 10 September 2026, under deductibility PC.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.